KIF1A Gene Mental Retardation Autosomal Dominant Type 9 Genetic Test
Overview
The KIF1A gene is associated with a condition called mental retardation, autosomal dominant type 9 (MRD9). This genetic test, known as Next-Generation Sequencing (NGS), is used to analyze the DNA sequence of the KIF1A gene to identify any mutations or variations that may be causing MRD9.
Symptoms and Diagnosis
MRD9 is a rare genetic disorder characterized by intellectual disability, developmental delays, and other neurological symptoms. Individuals with MRD9 may also experience problems with movement, speech, and coordination. The severity of symptoms can vary widely among affected individuals.
Test Details
The KIF1A Gene Mental Retardation Autosomal Dominant Type 9 Genetic Test is performed using NGS technology. This powerful genetic testing technique allows for the rapid and comprehensive analysis of a person’s DNA. It can detect a wide range of genetic mutations and variations, including small changes in the DNA sequence that may be responsible for causing MRD9.
Test Components and Price
- Components: KIF1A Gene Mental retardation autosomal dominant type 9 Genetic Test
- Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Test Type
Neurological Disorders
Referring Doctor and Test Department
Doctor: Neurologist
Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for KIF1A Gene Mental retardation, autosomal dominant type 9 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KIF1A Gene Mental retardation, autosomal dominant type 9.
Importance of Genetic Testing
By identifying specific mutations in the KIF1A gene, NGS testing can provide a definitive diagnosis of MRD9. This information can be crucial for understanding the underlying cause of a person’s symptoms and guiding appropriate medical management and genetic counseling.
Ordering Genetic Testing
NGS testing for MRD9 is typically ordered by a healthcare professional who specializes in genetics. They will consider an individual’s clinical symptoms, family history, and other relevant factors before recommending genetic testing. Genetic counseling is often recommended before and after testing to ensure a thorough understanding of the implications and limitations of the results.
Test Name | KIF1A Gene Mental retardation autosomal dominant type 9 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for KIF1A Gene Mental retardation, autosomal dominant type 9 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KIF1A Gene Mental retardation, autosomal dominant type 9 |
Test Details |
The KIF1A gene is associated with a condition called mental retardation, autosomal dominant type 9 (MRD9). This genetic test, known as Next-Generation Sequencing (NGS), is used to analyze the DNA sequence of the KIF1A gene to identify any mutations or variations that may be causing MRD9. MRD9 is a rare genetic disorder characterized by intellectual disability, developmental delays, and other neurological symptoms. Individuals with MRD9 may also experience problems with movement, speech, and coordination. The severity of symptoms can vary widely among affected individuals. NGS is a powerful genetic testing technique that allows for the rapid and comprehensive analysis of a person’s DNA. It can detect a wide range of genetic mutations and variations, including small changes in the DNA sequence that may be responsible for causing MRD9. By identifying specific mutations in the KIF1A gene, NGS testing can provide a definitive diagnosis of MRD9. This information can be crucial for understanding the underlying cause of a person’s symptoms and guiding appropriate medical management and genetic counseling. It is important to note that NGS testing for MRD9 is typically ordered by a healthcare professional who specializes in genetics. They will consider an individual’s clinical symptoms, family history, and other relevant factors before recommending genetic testing. Genetic counseling is often recommended before and after testing to ensure a thorough understanding of the implications and limitations of the results. |